Background: Ischemic heart disease is the leading cause of death in the world and is associated with dyslipidemia, high
blood pressure, diabetes mellitus, and other factors. Objective: To determine the clinical effectiveness on the lipid profile<
Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacoepidemiología
- Autores: "Manuel E. Machado-Duque, Andrés Gaviria-Mendoza, and Jorge E. Machado-Alba"
- Idiomas: Inglés
- Palabras clave: eficacia clínica, dislipidemias, fenofibrato, farmacoepidemiología, rosuvastatinaclinical effectiveness, dyslipidemias, fenofibrate, pharmacoepidemiology, rosuvastatin
Machado-Duque, M. E., Gaviria-Mendoza, A., & Machado-Alba, J. E. (2020). Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia. Journal of primary care & community hea Enlace: https://pubmed.ncbi.nlm.nih.gov/33251941/
